SEC Company Response from Gain Therapeutics, Inc. (GANX) (CIK 0001819411) (GANX) — May 31, 2022
Gain Therapeutics, Inc. (GANX) (CIK 0001819411)
Date: May 31, 2022 · CIK: 0001819411 · Accession: 0001104659-22-066685
AI Filing Summary & Sentiment
File numbers found in text: 333-265061
Letter
Re: Gain Therapeutics, Inc.
May 31,
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Registration Statement on Form S-3, as amended
File No. 333-265061
Acceleration Request
Requested Date: June 1, 2022
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-265061) (as amended, the “Registration Statement”) to become effective on Wednesday, June 1, 2022 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney T. Thorne of Cooley LLP, counsel to the Registrant, at (617) 937-2318.
Very
truly yours,
Gain
Therapeutics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
May 31,
2022
VIA EDGAR
U.S. Securities
and Exchange Commission
Division
of Corporation Finance
100 F Street,
N.E.
Washington,
D.C. 20549
Attn: Joshua
Gorsky
Re: Gain
Therapeutics, Inc.
Registration
Statement on Form S-3, as amended
File
No. 333-265061
Acceleration
Request
Requested Date:
June 1, 2022
Requested Time:
4:00 PM Eastern Daylight Time
Ladies and
Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”)
hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause
the Registration Statement on Form S-3 (File No. 333-265061) (as amended, the “Registration Statement”)
to become effective on Wednesday, June 1, 2022 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or
at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”).
The Registrant hereby authorizes Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once
the Registration Statement has been declared effective, please orally confirm that event with Courtney T. Thorne of Cooley LLP, counsel
to the Registrant, at (617) 937-2318.
Very
truly yours,
Gain
Therapeutics, Inc.
By:
/s/ Eric
I. Richman
Eric
I. Richman
Chief
Executive Officer
cc: Courtney
T. Thorne, Cooley LLP